tiprankstipranks
MeVis Medical Solutions AG (DE:M3V)
XETRA:M3V

MeVis Medical Solutions (M3V) Price & Analysis

Compare
2 Followers

M3V Stock Chart & Stats


---

Financials

Quarterly

M3V FAQ

What was MeVis Medical Solutions AG’s price range in the past 12 months?
MeVis Medical Solutions AG lowest stock price was €22.80 and its highest was €26.80 in the past 12 months.
    What is MeVis Medical Solutions AG’s market cap?
    MeVis Medical Solutions AG’s market cap is €46.23M.
      When is MeVis Medical Solutions AG’s upcoming earnings report date?
      MeVis Medical Solutions AG’s upcoming earnings report date is May 27, 2025 which is in 76 days.
        How were MeVis Medical Solutions AG’s earnings last quarter?
        MeVis Medical Solutions AG released its earnings results on Jan 30, 2025. The company reported €1.044 earnings per share for the quarter, beating the consensus estimate of N/A by €1.044.
          Is MeVis Medical Solutions AG overvalued?
          According to Wall Street analysts MeVis Medical Solutions AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does MeVis Medical Solutions AG pay dividends?
            MeVis Medical Solutions AG pays a Annually dividend of €0.949 which represents an annual dividend yield of 3.74%. See more information on MeVis Medical Solutions AG dividends here
              What is MeVis Medical Solutions AG’s EPS estimate?
              MeVis Medical Solutions AG’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does MeVis Medical Solutions AG have?
              MeVis Medical Solutions AG has 1,820,000 shares outstanding.
                What happened to MeVis Medical Solutions AG’s price movement after its last earnings report?
                MeVis Medical Solutions AG reported an EPS of €1.044 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.794%.
                  Which hedge fund is a major shareholder of MeVis Medical Solutions AG?
                  Currently, no hedge funds are holding shares in DE:M3V
                  ---

                  MeVis Medical Solutions Stock Smart Score

                  4
                  Neutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  -20.51%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  25.59%
                  Trailing 12-Months
                  Asset Growth
                  -5.60%
                  Trailing 12-Months

                  Company Description

                  MeVis Medical Solutions AG

                  MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Biotest
                  Draegerwerk AG & Co. KGaA
                  Fresenius Medical Care AG & Co. KGaA
                  Sartorius
                  BOE Varitronix
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis